Evry - 3 november
Thank you to the EuroNanoMed III for the grant provided for our project “Nanocarriers to deliver antibodies towards intracellular targets in cancer cells/TAMs at primary/metastatic sites” (2^2-INTRATARGET). Hybrigenics services will select nanobodies (nAbs) against intracellular targets from its patented synthetic library, providing new tools to mediate the intracellular degradation of key oncoproteins.